Navigation Links
Bypassing the insulin highway
Date:4/25/2008

An immune cell known as a neutrophil releases a protein that can suppress glucose production in the liver without targeting insulin, researchers have found.

Neutrophils, a type of white blood cell, produce special immune proteins called defensins which seem to have a connection with glucose levels. During bacterial infection, defensin production can increase dramatically, a rise that frequently results in hypoglycemia. In addition, many patients with type II diabetes have decreased defensin levels.

To study this connection further, Wenhong Cao and colleagues tested the effects of human defensin HNP-1 on both isolated cells and rodent models. Treating liver cells with HNP-1 suppressed the expression of several glucose-producing genes and decreased cellular glucose levels, but did not activate or alter the expression of the insulin receptor at all. This inhibition extended to animals, as HNP-1 reduced blood glucose levels in both normal mice and diabetic rats.

These findings provide some more information linking the immune system and metabolism, and also offer a new avenue to target diabetics who do not respond well to traditional insulin-based treatments.


'/>"/>

Contact: Nick Zagorski
nzagorski@asbmb.org
301-634-7366
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

Page: 1

Related biology news :

1. Insulins brain impact links drugs and diabetes
2. Botched production of insulin molecule may lead to diabetes
3. Drug could improve pregnancy outcomes in wider range of women with insulin resistance
4. Sugary drinks, not fruit juice, may be linked to insulin
5. New research reveals shark superhighways and hotspots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:4/14/2016)... April 14, 2016 BioCatch ... Detection, today announced the appointment of Eyal Goldwerger ... role. Goldwerger,s leadership appointment comes at a ... of the deployment of its platform at several of ... technology, which discerns unique cognitive and physiological factors, is ...
(Date:3/31/2016)... 31, 2016   ... the "Company") LegacyXChange is excited to release ... soon to be launched online site for trading 100% ... ) will also provide potential shareholders a sense of ... to an industry that is notorious for fraud. The ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)... BOSTON , June 27, 2016   Ginkgo ... biology to industrial engineering, was today awarded as ... a selection of the world,s most innovative companies. ... at scale for the real world in the ... organism engineers work directly with customers including Fortune ...
(Date:6/24/2016)... ... 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona combed ... pleural mesothelioma. Their findings are the subject of a new article on the Surviving ... signposts in the blood, lung fluid or tissue of mesothelioma patients that can help ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology: